Bruno M Costa

17PUBLICATIONS
45CO-AUTHORS
Gene and molecular therapyBiomaterialsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jun 04, 2025
Updating TCGA glioma classification through integration of molecular data following the latest WHO guidelines.

Mónica Leiria de Mendonça, Roberta Coletti, Céline S Gonçalves

|May 11, 2024
The Potential of the Fibronectin Inhibitor Arg-Gly-Asp-Ser in the Development of Therapies for Glioblastoma.

Maria L Castro-Ribeiro, Vânia I B Castro, Joana Vieira de Castro

|Jan 26, 2024
Relevance of HOTAIR rs920778 and rs12826786 Genetic Variants in Bladder Cancer Risk and Survival.

Eduarda P Martins, Joana Vieira de Castro, Rita Fontes

|Jan 22, 2022
Cadherin switches during epithelial-mesenchymal transition: CDH4/RCAD downregulation reduces bladder cancer progression.

Cláudia Martins-Lima, Vera Miranda-Gonçalves, João Lobo

|Dec 17, 2021
Cadherin-3 is a novel oncogenic biomarker with prognostic value in glioblastoma.

Eduarda P Martins, Céline S Gonçalves, Marta Pojo

|Nov 24, 2021
Plexin-A4 Mediates Cytotoxic T-cell Trafficking and Exclusion in Cancer.

Ward Celus, Ana I Oliveira, Silvia Rivis

Pageof 3